display
Erlangen / Munich (dpa / lby) - After purchasing 200,000 doses of a new corona drug for all of Germany, part of the drug is to be distributed to six university clinics in Bavaria.
Hospitals in the respective regions then get their needs from there, said a spokeswoman for the Ministry of Health in Munich on Saturday.
The new corona drugs, so-called monoclonal antibodies, are intended to help patients in the early phase of Covid-19 disease and prevent a severe course.
Nationwide, the costs are expected to amount to 400 million euros.
The Federal Ministry of Health had secured contingents of two of the so-called monoclonal antibody-containing drugs.
On the one hand, it concerns the antibody Bamlanivimab, which is being developed by the US pharmaceutical company Eli Lilly, and on the other hand the two antibodies casirivimab / imdevimab from the US manufacturer Regeneron, which are to be administered at the same time, it was said last weekend.
display
Monoclonal antibodies are made in the laboratory and are designed to disable the virus after infection.
Monoclonal means that the antibodies used are all the same and attack the virus at a clearly defined target.
According to information from Bayerischer Rundfunk, Erlangen University Hospital has already received such drugs.
These are intended for all of Middle and Upper Franconia.
In the USA, ex-President Donald Trump was also treated with such a drug.
© dpa-infocom, dpa: 210130-99-235324 / 2